Abbott Stock Performance

ABT
 Stock
  

USD 107.95  1.05  0.96%   

Abbott Laboratories has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.0034, which signifies a somewhat significant risk relative to the market. Let's try to break down what Abbott's beta means in this case. Abbott Laboratories returns are very sensitive to returns on the market. As the market goes up or down, Abbott Laboratories is expected to follow. Although it is important to respect Abbott Laboratories historical returns, it is better to be realistic regarding the information on the equity's current trending patterns. The philosophy in foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing Abbott Laboratories technical indicators, you can presently evaluate if the expected return of 0.0671% will be sustainable into the future. Abbott Laboratories right now shows a risk of 1.59%. Please confirm Abbott Laboratories value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall to decide if Abbott Laboratories will be following its price patterns.
  
Abbott Performance
3 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Abbott Laboratories are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable fundamental drivers, Abbott Laboratories is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more

Structure and Payout Changes

Forward Annual Dividend Yield
0.0172
Payout Ratio
0.32
Last Split Factor
10000:4798
Forward Annual Dividend Rate
1.88
Dividend Date
2022-08-15
Ex Dividend Date
2022-07-14
Last Split Date
2013-01-02

Abbott Price Channel

Fifty Two Week Low101.24
Target High Price158.50
Payout Ratio38.41%
Fifty Two Week High142.60
Target Low Price95.00
Trailing Annual Dividend Yield1.64%

Abbott Laboratories Relative Risk vs. Return Landscape

If you would invest  10,537  in Abbott Laboratories on May 11, 2022 and sell it today you would earn a total of  363.00  from holding Abbott Laboratories or generate 3.45% return on investment over 90 days. Abbott Laboratories is generating 0.0671% of daily returns assuming volatility of 1.5945% on return distribution over 90 days investment horizon. In other words, 13% of stocks are less volatile than Abbott, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Daily Expected Return (%)  
       Risk (%)  
Considering the 90-day investment horizon Abbott Laboratories is expected to generate 1.27 times more return on investment than the market. However, the company is 1.27 times more volatile than its market benchmark. It trades about 0.04 of its potential returns per unit of risk. The DOW is currently generating roughly 0.04 per unit of risk.

Abbott Laboratories Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Abbott Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Abbott Laboratories, and traders can use it to determine the average amount a Abbott Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0421

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
ABTHigh
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 1.59
  actual daily
 
 13 %
of total potential
 
1313
Expected Return
 0.07
  actual daily
 
 1 %
of total potential
 
11
Risk-Adjusted Return
 0.04
  actual daily
 
 3 %
of total potential
 
33
Based on monthly moving average Abbott Laboratories is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abbott Laboratories by adding it to a well-diversified portfolio.

About Abbott Laboratories Performance

To evaluate Abbott Laboratories Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Abbott Laboratories generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Abbott Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Abbott Laboratories stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Abbott's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Effect of Exchange Rate Changes on Cash-70 M-75.5 M
Return on Investment 15.99  14.55 
Return on Average Assets 0.1  0.08 
Return on Average Equity 0.20  0.16 
Return on Invested Capital 0.26  0.21 
Return on Sales 0.20  0.18 
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 113000 people.

Things to note about Abbott Laboratories

Checking the ongoing alerts about Abbott Laboratories for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Abbott Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Abbott Laboratories Alerts

Equity Alerts and Improvement Suggestions

Abbott Laboratories has a poor financial position based on the latest SEC disclosures
Over 76.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Abbott Laboratories exotic insider transaction detected
Please continue to Trending Equities. Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.73
Market Capitalization
191.3 B
Quarterly Revenue Growth YOY
0.1
Return On Assets
0.0896
Return On Equity
0.24
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Abbott Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.